{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:13:14Z","timestamp":1789913594302,"version":"4.0.1"},"reference-count":82,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00227","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T11:50:49Z","timestamp":1488801049000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis"],"prefix":"10.3389","volume":"8","author":[{"given":"Micheli Luize","family":"Barbosa Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirlei","family":"Nico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabr\u00edcia Alvisi","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Silva","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iam","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Mello","family":"de Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Morrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Santoro","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Palatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Bani-Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque Pacheco","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisa Beatriz","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1756-3305-4-197","article-title":"One Health: the global challenge of epidemic and endemic leishmaniasis","volume":"4","author":"Palatnik-de-Sousa","year":"2011","journal-title":"Parasit Vectors"},{"key":"B3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2217\/fmb.14.43","article-title":"Immunity to visceral leishmaniasis: implications for immunotherapy","volume":"9","author":"Khadem","year":"2014","journal-title":"Future Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","article-title":"Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4269\/ajtmh.2012.12-0180","article-title":"Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi","volume":"87","author":"Stober","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1086\/521682","article-title":"Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan","volume":"196","author":"Jeronimo","year":"2007","journal-title":"J Infect Dis"},{"key":"B7","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.4049\/jimmunol.138.11.3688","article-title":"Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones","volume":"138","author":"Cher","year":"1987","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/infdis\/165.3.535","article-title":"Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi","volume":"165","author":"Carvalho","year":"1992","journal-title":"J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin Transl Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fimmu.2014.00189","article-title":"Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+ epitopes of Leishmania donovani nucleoside hydrolase terminal domains","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fimmu.2014.00273","article-title":"Leishmania donovani nucleoside hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fmicb.2016.00467","article-title":"Post-genomics and vaccine improvement for Leishmania","volume":"7","author":"Seyed","year":"2016","journal-title":"Front Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/j.1469-0691.2011.03610.x","article-title":"Visceral leishmaniasis: immunology and prospects for a vaccine","volume":"17","author":"Kaye","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1016\/j.vaccine.2012.03.068","article-title":"Leishmaniasis: vaccine candidates and perspectives","volume":"30","author":"Singh","year":"2012","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"The FML-vaccine against canine visceral leishmaniasis: from the second generation to the synthetic vaccine","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Exp Rev Vaccines"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune\u00ae) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","article-title":"Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs","volume":"23","author":"Nogueira","year":"2005","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0124183","DOI":"10.1371\/journal.pone.0124183","article-title":"Immucillins impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis multiplication in vitro","volume":"10","author":"Freitas","year":"2015","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0004297","DOI":"10.1371\/journal.pntd.0004297","article-title":"Immucillins ImmA and ImmH are effective and non-toxic in the treatment of experimental visceral leishmaniasis","volume":"9","author":"Freitas","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1016\/S0264-410X(01)00031-7","article-title":"Vaccination of Balb\/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani","volume":"19","author":"Paraguai de Souza","year":"2001","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2007.77.1060","article-title":"Protection of susceptible BALB\/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania","volume":"77","author":"Al-Wabel","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect Immun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1371\/journal.pntd.0000866","article-title":"Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response","volume":"4","author":"Nico","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.provac.2009.07.019","article-title":"Nucleoside hydrolase DNA vaccine against visceral leishmaniasis","volume":"1","author":"Borja-Cabrera","year":"2009","journal-title":"Procedia Vaccinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1016\/j.vaccine.2006.03.005","article-title":"Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani","volume":"24","author":"Gamboa-Le\u00f3n","year":"2006","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijpara.2006.03.006","article-title":"Towards multilocus sequence typing of the Leishmania donovani complex: resolving genotypes and haplotypes for five polymorphic metabolic enzymes (ASAT, GPI, NH1, NH2, PGD)","volume":"36","author":"Mauricio","year":"2006","journal-title":"Int J Parasitol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0378-1119(01)00768-5","article-title":"A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite","volume":"280","author":"Cui","year":"2001","journal-title":"Gene"},{"key":"B31","volume-title":"Blast-Basic Local Alignment Search Tool","year":"2014"},{"key":"B32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.coph.2008.08.002","article-title":"Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates","volume":"8","author":"De Groot","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bbapap.2009.02.011","article-title":"Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors","volume":"1794","author":"Vers\u00e9es","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1021\/bi702448s","article-title":"Structural basis for substrate specificity in group I nucleoside hydrolases","volume":"47","author":"Iovane","year":"2008","journal-title":"Biochemistry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S0037-86821996000200008","article-title":"The FML (Fucose Mannose Ligand) of Leishmania donovani. A new tool in diagnosis, prognosis, transfusional control and vaccination against human Kala-azar","volume":"29","author":"Palatnik de Sousa","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"key":"B36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.provac.2009.07.021","article-title":"Cloning of the Nucleoside hydrolase of Leishmania donovani aiming at the development of a synthetic vaccine against visceral leishmaniasis","volume":"1","author":"Nico","year":"2009","journal-title":"Procedia Vaccinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpara.2004.11.003","article-title":"Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen","volume":"35","author":"Rodrigues","year":"2005","journal-title":"Int J Parasitol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/prep.2002.1628","article-title":"Cloning, overexpression, purification and matrix-assisted refolding of DevS (Rv 3132c) histidine protein kinase of Mycobacterium tuberculosis","volume":"25","author":"Saini","year":"2002","journal-title":"Protein Expr Purif"},{"key":"B39","doi-asserted-by":"publisher","first-page":"21114","DOI":"10.1074\/jbc.274.30.21114","article-title":"Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-\u00e5 crystal structure","volume":"274","author":"Shi","year":"1999","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1046\/j.1365-2567.2004.01948.x","article-title":"CD4+ CCR5+ and CD4+ CCR3+ lymphocyte subset and monocyte apoptosis in patients with acute visceral leishmaniasis","volume":"113","author":"Potestio","year":"2004","journal-title":"Immunology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/00365540410020451","article-title":"An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil","volume":"36","author":"Jeronimo","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.gene.6364422","article-title":"Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection","volume":"8","author":"Jeronimo","year":"2007","journal-title":"Genes Immun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0035-9203(82)90095-5","article-title":"Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya","volume":"76","author":"Ho","year":"1982","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0035-9203(79)90159-7","article-title":"A field trial of a vaccine against American dermal leishmaniasis","volume":"73","author":"Mayrink","year":"1979","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/ije\/15.4.572","article-title":"Controlled field trials of a vaccine against new world cutaneous leishmaniasis","volume":"15","author":"Antunes","year":"1986","journal-title":"Int J Epidemiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, doubleblind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1172\/JCI112209","article-title":"Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis","volume":"76","author":"Carvalho","year":"1985","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4049\/jimmunol.138.3.908","article-title":"An analysis of T cell responsiveness in Indian kala-azar","volume":"138","author":"Sacks","year":"1987","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.4049\/jimmunol.179.8.5592","article-title":"IL-10 and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India","volume":"179","author":"Saha","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"B50","doi-asserted-by":"publisher","first-page":"e0141265","DOI":"10.1371\/journal.pone.0141265","article-title":"Soluble CD40 ligand in sera of subjects exposed to Leishmania infantum infection reduces the parasite load in macrophages","volume":"10","author":"de Oliveira","year":"2015","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm.3221","article-title":"Inflammasome-derived IL-1\u03b2 production induces nitric oxide-mediated resistance to Leishmania","volume":"19","author":"Lima-Junior","year":"2013","journal-title":"Nat Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/cyto.a.20256","article-title":"Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis","volume":"69","author":"Kurkjian","year":"2006","journal-title":"Cytometry A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1179\/2047773213Y.0000000078","article-title":"Serum cytokines associated with severity and complications of kala-azar","volume":"107","author":"Costa","year":"2013","journal-title":"Pathog Glob Health"},{"key":"B54","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1590\/S0074-02762012000600005","article-title":"Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis","volume":"107","author":"Costa","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"B55","doi-asserted-by":"publisher","first-page":"e0004422","DOI":"10.1371\/journal.pntd.0004422","article-title":"Induction of IL-10 and TGF\u03b2 from CD4+CD25+FoxP3+ T cells correlates with parasite load in Indian kala-azar patients infected with Leishmania donovani","volume":"10","author":"Bhattacharya","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/S2214-109X(13)70118-9","article-title":"Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study","volume":"2","author":"Mondal","year":"2014","journal-title":"Lancet Glob Health"},{"key":"B57","first-page":"186","article-title":"Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis. Spleen size regression in cure","volume":"47","author":"Sundar","year":"1999","journal-title":"J Assoc Physicians India"},{"issue":"4","key":"B58","doi-asserted-by":"publisher","first-page":"e0003699","DOI":"10.1371\/journal.pntd.0003699","article-title":"Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh","volume":"9","author":"Lucero","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nyl\u00e9n","year":"2007","journal-title":"Trends Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/ni861","article-title":"Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis","volume":"3","author":"Ato","year":"2002","journal-title":"Nat Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e92708","DOI":"10.1371\/journal.pone.0092708","article-title":"In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis","volume":"9","author":"Chamakh-Ayari","year":"2014","journal-title":"PLoS One"},{"key":"B62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.0105-2896.2004.00188.x","article-title":"The immunopathology of experimental visceral leishmaniasis","volume":"201","author":"Kaye","year":"2004","journal-title":"Immunol Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"E54","DOI":"10.1086\/340261","article-title":"Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection","volume":"34","author":"Follador","year":"2002","journal-title":"Clin Infect Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.vetimm.2004.08.010","article-title":"Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis","volume":"103","author":"Chamizo","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6937980","DOI":"10.1155\/2016\/6937980","article-title":"Serum cytokine responses over the entire clinical-immunological spectrum of human Leishmania (L.) infantum chagasi infection","volume":"2016","author":"Ramos","year":"2016","journal-title":"Biomed Res Int"},{"key":"B66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1084\/jem.20040172","article-title":"Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon g-producing CD8+ T cells","volume":"199","author":"Uzonna","year":"2004","journal-title":"J Exp Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e3300","DOI":"10.1371\/journal.pntd.0003300","article-title":"CD8+ T cells are preferentially activated during primary low dose Leishmania major infection but are completely dispensable during secondary anti-Leishmania immunity","volume":"8","author":"Okwor","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1002\/eji.1830221206","article-title":"Role of T cell subsets during the recall of immunologic memory to Leishmania major","volume":"22","author":"M\u00fcller","year":"1992","journal-title":"Eur J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4049\/jimmunol.165.2.915","article-title":"Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells","volume":"165","author":"Gurunathan","year":"2000","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","article-title":"The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose intradermal challenge","volume":"166","author":"Mendez","year":"2001","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1747-0285.2009.00825.x","article-title":"Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti-pilus vaccine for Pseudomonas aeruginosa","volume":"74","author":"Kao","year":"2009","journal-title":"Chem Biol Drug Des"},{"key":"B73","doi-asserted-by":"publisher","first-page":"26951","DOI":"10.1074\/jbc.M109.013706","article-title":"Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate","volume":"284","author":"Plassmeyer","year":"2009","journal-title":"J Biol Chem"},{"key":"B74","doi-asserted-by":"publisher","first-page":"594109","DOI":"10.1155\/2015\/594109","article-title":"Receptor binding domain based HIV vaccines","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"key":"B75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/14760584.2017.1240041","article-title":"M2-based influenza vaccines: recent advances and clinical potential","volume":"16","author":"Kolpe","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B76","doi-asserted-by":"publisher","first-page":"14907","DOI":"10.1074\/jbc.M511571200","article-title":"Major histocompatibility complex and T cell interactions of a universal T-cell epitope from Plasmodium falciparum circumsporozoite protein","volume":"281","author":"Parra-L\u00f3pez","year":"2006","journal-title":"J Biol Chem"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.micinf.2007.05.017","article-title":"Different epitopes of the LACK protein are recognized by V beta 4 V alpha 8 CD4+ T cells in H-2b and H-2d mice susceptible to Leishmania major","volume":"9","author":"Launois","year":"2007","journal-title":"Microbes Infect"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages","volume":"195","author":"Basu","year":"2007","journal-title":"J Infect Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e0124786","DOI":"10.1371\/journal.pone.0124786","article-title":"Prediction of CD8+ epitopes in Leishmania braziliensis proteins using EPIBOT: in silico search and in vivo validation","volume":"10","author":"Duarte","year":"2015","journal-title":"PLoS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1440-1711.2002.01092.x","article-title":"Immuno-informatics: mining genomes for vaccine components","volume":"80","author":"De Groot","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4172\/1948-5948.1000250","article-title":"Assessment of protection induced by DNA and live vaccine encoding Leishmania MHC class I restricted epitopes against L. major challenge in Balb\/c mice model","volume":"7","author":"Zandieh","year":"2015","journal-title":"J Microb Biochem Technol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00227\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T13:42:35Z","timestamp":1692711755000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00227\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":82,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00227","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]}}}